Rigel Pharmaceuticals, Inc.【RIGL】 流動負債合計の推移
機能の使い方
|
（単位：千ドル）
|
流動負債合計
|
前年比（％）
|
|
4Q25
|
99,237
|
+56.8%
|
|
3Q25
|
94,400
|
+73.8%
|
|
2Q25
|
86,636
|
+47.7%
|
|
1Q25
|
66,629
|
-9.0%
|
|
4Q24
|
63,299
|
+18.8%
|
|
3Q24
|
54,312
|
+12.5%
|
|
2Q24
|
58,649
|
+33.2%
|
|
1Q24
|
73,198
|
+60.8%
|
|
4Q23
|
53,267
|
-18.3%
|
|
3Q23
|
48,273
|
+2.1%
|
|
2Q23
|
44,023
|
-19.9%
|
|
1Q23
|
45,518
|
-23.1%
|
|
4Q22
|
65,211
|
+2.6%
|
|
3Q22
|
47,265
|
-20.3%
|
|
2Q22
|
54,955
|
-7.7%
|
|
1Q22
|
59,225
|
+13.8%
|
|
4Q21
|
63,554
|
+55.6%
|
|
3Q21
|
59,282
|
+73.4%
|
|
2Q21
|
59,544
|
+71.3%
|
|
1Q21
|
52,022
|
+66.9%
|
|
4Q20
|
40,841
|
-29.8%
|
|
3Q20
|
34,192
|
+10.3%
|
|
2Q20
|
34,760
|
+22.5%
|
|
1Q20
|
31,172
|
+19.3%
|
|
4Q19
|
58,212
|
+109.9%
|
|
3Q19
|
31,006
|
+57.4%
|
|
2Q19
|
28,380
|
+63.4%
|
|
1Q19
|
26,138
|
+39.1%
|
|
4Q18
|
27,734
|
+51.2%
|
|
3Q18
|
19,696
|
+31.3%
|
|
2Q18
|
17,365
|
+9.4%
|
|
1Q18
|
18,790
|
+9.0%
|
|
4Q17
|
18,337
|
-18.8%
|
|
3Q17
|
15,006
|
-27.3%
|
|
2Q17
|
15,873
|
-27.9%
|
|
1Q17
|
17,245
|
-37.8%
|
|
4Q16
|
22,588
|
-33.2%
|
|
3Q16
|
20,632
|
-40.8%
|
|
2Q16
|
22,001
|
-35.6%
|
|
1Q16
|
27,711
|
-19.3%
|
|
4Q15
|
33,796
|
+141.0%
|
|
3Q15
|
34,838
|
+241.5%
|
|
2Q15
|
34,174
|
+239.5%
|
|
1Q15
|
34,349
|
+336.7%
|
|
4Q14
|
14,025
|
+36.2%
|
|
3Q14
|
10,201
|
+22.9%
|
|
2Q14
|
10,065
|
+18.8%
|
|
1Q14
|
7,865
|
-14.1%
|
|
4Q13
|
10,294
|
-15.7%
|
|
3Q13
|
8,303
|
-21.6%
|
|
2Q13
|
8,472
|
-10.8%
|
|
1Q13
|
9,158
|
+13.9%
|
|
4Q12
|
12,204
|
+5.9%
|
|
3Q12
|
10,585
|
+25.7%
|
|
2Q12
|
9,500
|
+22.0%
|
|
1Q12
|
8,039
|
-
|
|
4Q11
|
11,527
|
-
|
|
3Q11
|
8,422
|
-
|
|
2Q11
|
7,785
|
-
|